Serial biomarker measurements may be helpful to predict the successful application of high flow nasal cannula in COVID-19 pneumonia patients

Serial biomarker measurements may be helpful to predict the successful application of high flow nasal cannula in COVID-19 pneumonia patients

Abstract High flow nasal cannula (HFNC) can reduce the need for intubation in patients with coronavirus disease-19 (COVID-19) pneumonia induced acute hypoxemic respiratory failure (AHRF), but predictors of HFNC success could be characterized better. C-reactive protein (CRP) and D-dimer are associate...

Full description

Saved in:
Bibliographic Details
Main Authors: Reid Ikeda, Andrew Pham, Guangxiang Zhang, Jennifer F. Lai, James Davis, Gehan Devendra
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Biomarker
COVID-19
C-reactive protein
High flow nasal cannula
Pneumonia
Online Access:https://doi.org/10.1038/s41598-025-85210-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-85210-z

Similar Items